IOVANCE BIOTHERAPEUTICS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Iovance Biotherapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -45.5 %, a 18.6% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2023 was -55.3 %, a 12% increase from 2022.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2022 was -62.8 %, a 47.2% decline from 2021.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2021 was -42.7 %, a 9.13% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -55.3 +7.54 +12% Jan 1, 2023 Dec 31, 2023
2022 -62.8 -20.1 -47.2% Jan 1, 2022 Dec 31, 2022
2021 -42.7 -3.57 -9.13% Jan 1, 2021 Dec 31, 2021
2020 -39.1 +9.16 +19% Jan 1, 2020 Dec 31, 2020
2019 -48.3 -11.5 -31.2% Jan 1, 2019 Dec 31, 2019
2018 -36.8 +22.4 +37.8% Jan 1, 2018 Dec 31, 2018
2017 -59.1 -26.5 -81.3% Jan 1, 2017 Dec 31, 2017
2016 -32.6 -7.83 -31.6% Jan 1, 2016 Dec 31, 2016
2015 -24.8 +23.1 +48.2% Jan 1, 2015 Dec 31, 2015
2014 -47.9 +5.8 +10.8% Jan 1, 2014 Dec 31, 2014
2013 -53.7 +6.54K +99.2% Jan 1, 2013 Dec 31, 2013
2012 -6.6K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.